The children whose CKD onset was stage 2 and 3 carried mutations in PAX2 and HNF1B genes (11/24, 45.8%), whereas those whose CKD onset was stage 4 and 5 mostly carried mutations in NPHP genes (19/45, 42.2%). Here, PAX2 is linked to chronic kidney disease.